KP
Kyle Piskel (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $3.2M of ADPT (162,820 sh × $19.50, as filed), executed Nov 28 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.4M
shares × price, as filed
Last traded
Mar 11
Filed Mar 13
Median ADV $72.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ADPTRecent filings
ADPTSALE
Adaptive Biotechnologies Corporation
View filing →
$246K18,672 sh × $13.17
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $3.2M
162,820 sh × $19.50
Exec Nov 28 2025
Filed Dec 2 2025 · 5:30 PM ET